CDK4 and osteosarcoma: Within the group of MDM2 and/or CDK4 amplified osteosarcomas, the TP53 mutational status seems to have a profound effect on the global gene expression pattern, with TP53-mutated osteosarcomas clustering separately from TP53-wildtype tumours.